Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Experimental and Therapeutic Medicine|October 29, 2025
Effects of disaccharide and cationic lipid types on reverse transfection with lyophilized mRNA lipoplexesRyohei Shimizu, Yoshiyuki Hattori
Biomedical Reports|December 25, 2024
Effective mRNA transfection of tumor cells using cationic triacyl lipid‑based mRNA lipoplexesYoshiyuki Hattori, Ryohei Shimizu
Journal of Vision|January 17, 2009
Spatial attention in early vision for the perception of border ownershipNobuhiko Wagatsuma, Ryohei Shimizu, Ko Sakai
Journal of Photochemistry and Photobiology. B, Biology|January 4, 2019
Suppression of riboflavin-sensitized singlet oxygen generation by l-ascorbic acid, 3-O-ethyl-l-ascorbic acid and TroloxRyohei Shimizu, Mikio Yagi, Azusa Kikuchi
Life Sciences|November 3, 2024
Neudesin, a secretory protein, attenuates activation of lipopolysaccharide-stimulated macrophages by suppressing the Jak/Stat1/iNOS pathwayYoshiaki Nakayama, Yuki Masuda, Ryohei Shimizu, et al.
Neural Networks : the Official Journal of the International Neural Network Society|June 27, 2012
Consistent and robust determination of border ownership based on asymmetric surrounding contrastKo Sakai, Haruka Nishimura, Ryohei Shimizu, et al.
Journal of Liposome Research|May 5, 2025
Optimization of PEGylation for cationic triacyl lipid-based siRNA lipoplexes prepared using the modified ethanol injection method for tumor therapyYoshiyuki Hattori, Mizuki Shinkawa, Aya Kurihara, et al.
Angewandte Chemie (International Ed. in English)|June 23, 2015
Copper-Catalyzed Regioselective Hydroalkylation of 1,3-Dienes with Alkyl Fluorides and Grignard ReagentsTakanori Iwasaki, Ryohei Shimizu, Reiko Imanishi, et al.
Clinical Immunology (Orlando, Fla.)|October 6, 2024
Neudesin regulates dendritic cell function and antitumor CD8<sup>+</sup> T cell immunityYuki Masuda, Naoto Kondo, Yoshiaki Nakayama, et al.
Biological & Pharmaceutical Bulletin|April 14, 2024
Maitake Beta-Glucan Enhances the Therapeutic Effect of Trastuzumab via Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent CytotoxicityYuki Masuda, Shizuka Yamashita, Yoshiaki Nakayama, et al.
Pageof 3